More about
Sotalol
News
May 18, 2023
9 min read
Save
Improving safety, reducing length of stay for sotalol and dofetilide initiation in AF
Atrial fibrillation is common, affecting approximately 5.2 million patients in 2010 in the United States, and this is projected to increase to 12.1 million in 2030.
Part of the Healio Network
Sotalol Topic Review
Sotalol is a class III antiarrhythmic drug and acts by blocking cardiac potassium channels.